Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2000
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045794A1 Edible coating composition
08/10/2000WO2000045793A1 Ph independent extended release pharmaceutical formulation
08/10/2000WO2000045792A1 Hydrogel particle formulations
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045790A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/10/2000WO2000045789A1 Anti-plaque emulsions and products containing same
08/10/2000WO2000045778A1 Hair treatment compositions comprising c20 or higher unsaturated fatty acid polyester of cyclic polyols
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000045648A1 Method of preparing microparticles of phytosterols or phytostanols
08/10/2000WO2000032635A3 Tumor specific human monoclonal antibodies and methods of use
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000027372A8 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
08/10/2000WO2000026185A3 Omeprazole solution and method of using same
08/10/2000WO2000024360A3 Preparation and use of solidified oils
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000013665A9 Controlled release drug delivery
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19904847A1 Öl-in-Wasser-Mikroemulsion enthaltend Alkanolammonium-Salze der Alkylsulfate und/oder Alkylpolyalkylenglykolethersulfate Oil-in-water microemulsion containing alkanol ammonium salts of alkyl sulfates and / or alkylpolyalkyleneglycolethersulfates
08/10/2000DE19901085A1 Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps Transdermal therapeutic system with a self-adhesive matrix containing organic acid-addition salts of morphine alkaloids of the or Morphinantyps
08/10/2000CA2361832A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
08/10/2000CA2361807A1 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361555A1 Hydrogel particle formulations
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361543A1 Hair treatment compositions comprising c20 or higher unsaturated fatty acid polyester of cyclic polyols
08/10/2000CA2361539A1 Compressed lecithin preparations
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2360941A1 Liposome composition and method for administration of a radiosensitizer
08/10/2000CA2360835A1 Method of preparing microparticles of phytosterols or phytostanols
08/10/2000CA2358490A1 Anti-plaque emulsions and products containing same
08/10/2000CA2298214A1 Pharmaceutical solid dispersions
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026171A1 Polymer modification
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025861A1 Pharmaceutical compositions of hydrophobically modified Hedgehog Proteins and their use
08/09/2000EP1025860A2 Protein-containing hydrogels
08/09/2000EP1025859A1 Powdery pernasal compositions
08/09/2000EP1025858A1 Medicinal compositions with relieved bitterness, etc.
08/09/2000EP1025848A1 Sustained-release theophylline tablet
08/09/2000EP1025846A1 Aqueous liquid preparations
08/09/2000EP1025843A2 Pressure sensitive adhesive compositions for transdermal drug delivery devices
08/09/2000EP1025840A2 Oral drug compositions and methods
08/09/2000EP1025230A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
08/09/2000EP1024836A1 Method of delivering genes to antigen presenting cells of the skin
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
08/09/2000EP1024834A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/09/2000EP1024833A1 Pharmaceutical composition containing acid addition salt of basic drug
08/09/2000EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
08/09/2000EP1024824A1 Solid dispersing vaccine composition for oral delivery
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024795A1 Controlled release formulations
08/09/2000EP1024794A1 Methods of treating capsules and dry, powdered pharmaceutical formulations
08/09/2000EP1024792A1 Topical antifungal composition
08/09/2000EP1024790A1 Injectable biodegradable block copolymer gels for use in drug delivery
08/09/2000EP1024784A1 Beta-d glucan topical composition
08/09/2000EP1006964A4 Intrauterine chemical necrosing method, composition, and apparatus
08/09/2000EP0799024B1 Pharmaceutical aerosol containing at least one sugar
08/09/2000EP0774898A4 Methods of making sustained release biocidal compositions
08/09/2000EP0763056B1 Use of surfactants for stabilization of peptides and proteins for radiopharmaceutical use
08/09/2000EP0732915B1 Local delivery of fibrinolysis enhancing agents
08/09/2000EP0640622B1 Polysaccharide derivative and drug carrier
08/09/2000CN1262626A Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
08/09/2000CN1262619A Process for preparing reactive pharmaceutical product for detection of gastrointestinal disorder caused by bacteria
08/09/2000CN1262131A Microbe protection with trehalose instead of human serum albumin and microbe preparation
08/09/2000CN1262130A Application of complexon in veterinary medicines
08/09/2000CN1262129A Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof
08/08/2000US6100338 Graft copolymer whose graft chain is poly n-alkylacrylamide or poly n-alkylmethacrylamide, graft copolymer having polyacrylic acid or polymethacrylic acid as graft copolymers, graft polymers having polyvinyl amine graft polymer; drug delivery
08/08/2000US6100302 Propofol formulation with enhanced microbial characteristics
08/08/2000US6100298 Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery
08/08/2000US6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
08/08/2000US6100285 Method of solubilizing itraconazole
08/08/2000US6099868 Method of using potassium nitrate for pain reduction
08/08/2000US6099856 Increased bioavailable
08/08/2000US6099853 Vaccine containing deactivated bacteria
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000US6099837 Pharmaceutical preparation for treating blood coagulation disorders
08/08/2000US6099829 Comprising cross-linked, water-swellable polymers, where the oil phase consists of one or more fatty acid esters
08/08/2000US6099562 Drug coating with topcoat
08/08/2000CA2125904C Controlled release formulations coated with aqueous dispersions of ethylcellulose
08/08/2000CA2030670C Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
08/08/2000CA2011050C Human monocyte-machrophage-csf preparations
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341077C Luminide and macroluminide class of pharmaceuticals
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044808A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044785A1 Gcsf conjugates
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044401A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/03/2000WO2000044393A2 Buccal delivery system for proteinaceous medicaments
08/03/2000WO2000044369A1 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
08/03/2000WO2000044367A2 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000WO2000044356A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
08/03/2000WO2000044353A1 Pharmaceutical compositions
08/03/2000WO2000044351A1 Fast dispersing dosage forms free of gelatin
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044348A2 Materials and methods for making improved micelle compositions
1 ... 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 ... 1712